BELIMUMAB: ADVANCES IN DRUG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS

BELIMUMAB: ADVANCES IN DRUG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS

Saved in:

Bibliographic Details
Main Authors:	Evgeny Lvovich Nasonov, T M Reshetnyak, L N Denisov, M L Stanislav, S K Solovyov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2012-10-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1088
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. A. Aseeva, et al.
Published: (2015-09-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

New possibilities of pharmacotherapy for systemic lupus erythematosus: A place of belimumab
by: E. L. Nasonov
Published: (2014-12-01)

Pharmacoeconomic analysis of rituximab and belimumab therapy in patients with systemic lupus erythematosus
by: D. A. Gerasimova, et al.
Published: (2024-10-01)

Long-term belimumab therapy in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2024-08-01)

RESULTS OF AN OBSERVATIONAL PROSPECTIVE STUDY OF THE EFFICACY AND SAFETY OF BELIMUMAB (BENLYSTA®) IN SYSTEMIC LUPUS ERYTHEMATOSUS IN REAL CLINICAL PRACTICE
by: E. A. Aseeva, et al.
Published: (2016-03-01)

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus
by: A. G. Tolkushin, et al.
Published: (2018-11-01)

Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
by: E. L. Nasonov, et al.
Published: (2021-09-01)

GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01)

Long-term results of therapy with sequential use of rituximab and belimumab in patients with systemic lupus erythematosus
by: S. K. Solovyev, et al.
Published: (2023-10-01)

Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain
by: Silvia Díaz-Cerezo, et al.
Published: (2015-02-01)

Aspergillosis in systemic lupus erythematosus
by: T. M. Reshetnyak, et al.
Published: (2016-05-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01)

Aminoquinoline drugs in the treatment of systemic lupus erythematosus and antiphospholipid syndrome
by: L V Kondratyeva, et al.
Published: (2008-08-01)

Systemic lupus erythematosus and pregnancy: Before gestation, during and after childbirth
by: T. M. Reshetnyak, et al.
Published: (2023-06-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Experience of long-term belimumab use in patients with systemic lupus erythematosus (a case report)
by: Natalia Gennadyevna Klyukvina
Published: (2013-06-01)

Systematic Review and Meta-Analysis of the Efficacy and Safety Profile of Belimumab in Combination with Standard Therapy for Adults with Systemic Lupus Erythematosus
by: Mochamad Rangga Alif Dharmawan, et al.
Published: (2025-01-01)

INTERLEUKIN-17 IS A NEW TARGET FOR ANTI-CYTOKINE THERAPY OF IMMUNE INFLAMMATORY RHEUMATIC DISEASES
by: Evgeny Lvovich Nasonov, et al.
Published: (2013-12-01)

Neuropsychic manifestations in the Kyrgyz cohort of patients with systemic lupus erythematosus
by: G. M. Koylubaeva, et al.
Published: (2019-03-01)

A Rare Case of Prototheca Algaemia in a Patient with Systemic Lupus Erythematosus and Recent Belimumab Infusion
by: Carolina Mejia-Otero, et al.
Published: (2012-01-01)

Belimumab in a Patient with Systemic Lupus Erythematosus with Juvenile Onset and Steroid-induced Diabetes: Clinical Case
by: Maria I. Kaleda, et al.
Published: (2023-12-01)

Belimumab in the treatment of systemic lupus erythematosus with juvenile onset: Results of a single-center retrospective study
by: Maria I. Kaleda, et al.
Published: (2024-09-01)

Integrative miRNA-mRNA profiling uncovers mechanisms of belimumab action in systemic lupus erythematosus
by: Maria Royo, et al.
Published: (2025-03-01)

The clinical course and standard therapy of systemic lupus erythematosus in the Russian Federation
by: E. L. Nasonov, et al.
Published: (2016-06-01)

PROSPECTS FOR PHARMACOTHERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. L. Nasonov, et al.
Published: (2014-06-01)

Genetically engineered biological agents in therapy for systemic lupus erythematosus
by: Elena Aleksandrovna Aseeva, et al.
Published: (2013-10-01)

Systemic lupus erythematosus: new horizons for diagnosis and therapy
by: S. K. Solovyev, et al.
Published: (2020-02-01)

Real-World Effectiveness of Intravenous Belimumab on Clinical Outcomes in Patients With Systemic Lupus Erythematosus in Saudi Arabia: The OBSErve Observational Study
by: Al-Homood IA, et al.
Published: (2025-02-01)

Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old
by: article editorial
Published: (2020-02-01)

Recurrent Palpitation in a Young Man with Systemic Lupus Erythematosus Undergoing Belimumab with Resolution After Switching to Telitacicept
by: Yanfen Mai, et al.
Published: (2024-01-01)

Real-world effectiveness of belimumab and anifrolumab in systemic lupus erythematosus: comparable trends in disease activity and glucocorticoid reduction
by: Ryota Sato, et al.
Published: (2025-07-01)

OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: N V Seredavkina, et al.
Published: (2009-12-01)

Clinical application of belimumab in lupus nephritis
by: Zhou Han, et al.
Published: (2022-10-01)

Systemic lupus erythematosus: history and modernity
by: E. L. Nasonov, et al.
Published: (2022-09-01)

DUAL THERAPY WITH BIOLOGICALS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. A. Mesnyankina, et al.
Published: (2016-07-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
by: K. S. Nurbaeva, et al.
Published: (2021-10-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
by: Hong Huang, et al.
Published: (2021-04-01)

Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus
by: Christopher F Bell, et al.
Published: (2021-04-01)